A relatively increased number of false-positive cases were observed for the following AML groups: t(8;21) AML (9/118 negative cases), inv(16)/t(16;16) AML (6/119 negative cases), and KMT2A(MLL) AML (8/117 negative cases). This evidence concerns the gene KMT2A and acute myeloid leukemia.